Monster (MNST) Pressured Again on Litigation Concerns, Goldman Downgrade
Tweet
Share
E-mailGet Alerts MNST Hot Sheet
Join SI Premium – FREE
Monster Beverage (Nasdaq: MNST) is continuing to get pounded Tuesday following a 14 percent slide Monday on a report in the NY Times that the FDA has said it received several incident reports tying the popular energy drink to possible deaths.
This morning, Goldman Sachs took it to Monster, removing it from Conviction Buy while cutting its price target by $13 to $62.
Shares of Monster are down over 10 percent today, for a two-session drop of 23.2 percent.
This morning, Goldman Sachs took it to Monster, removing it from Conviction Buy while cutting its price target by $13 to $62.
Shares of Monster are down over 10 percent today, for a two-session drop of 23.2 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Reddit (RDDT) added to S&P 500
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Avalonbay Communities (AVB) dropped from S&P 500
Create E-mail Alert Related Categories
Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
